The calypso beacons will be provided free of charge for this study and there will be no additional costs to the patient or the Radiation Oncology Department for patients enrolling in this study. No additional risks are anticipated for patients enrolled in this study compared to the current standard of care treatment. The only "tests" that are part of our protocol that are outside of the standard of care for the treatment of intact cervical cancer would be the use of the (1) Calypso array used to localize the calypso "beacons" and (2) daily cone-beam CT scans to evaluate cervical cancer response to therapy. The Radiation Oncology department regularly uses both systems for patient set-up for other solid tumors and there will be no additional charge for these tests.